Concepedia

Author

Yusei Yamada

Kumamoto UniversityORCID

Also Known As

Y Yamada, Y. Yamada, Yusei Yamada

31

Publications

346

Citations

10

H-Index

27

Concepts

All Affiliations

Kumamoto UniversityTottori UniversitySaga UniversityDaiichi University of PharmacySojo University
YY

About

Yusei Yamada is an author at Kumamoto University specializing in medicine, pharmacology, and lysosomal storage disease.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

136

2

Engineering

1

1

40

3

Biochemistry

1

1

85

4

Electrical Engineering

1

1

40

5

Immunology

1

1

51

Yusei Yamada

×

10

Publications

324

Citations

10

H-Index

YearCitations

Efficacy of 2-Hydroxypropyl-β-cyclodextrin in Niemann–Pick Disease Type C Model Mice and Its Pharmacokinetic Analysis in a Patient with the Disease

Y. Tanaka, Yusei Yamada, Yoichi Ishitsuka,

Biological and Pharmaceutical Bulletin

2015

85

The exacerbating roles of CCAAT/enhancer-binding protein homologous protein (CHOP) in the development of bleomycin-induced pulmonary fibrosis and the preventive effects of tauroursodeoxycholic acid (TUDCA) against pulmonary fibrosis in mice

Y. Tanaka, Yoichi Ishitsuka, Marina Hayasaka,

Pharmacological Research

2015

51

Test results on hybrid photodiodes

N. Kanaya, Yuki Fujii, K. Hara,

Nuclear Instruments and Methods in Physics Research Section A Accelerators Spectrometers Detectors and Associated Equipment

1999

40

Intracerebroventricular Treatment with 2-Hydroxypropyl-β-Cyclodextrin Decreased Cerebellar and Hepatic Glycoprotein Nonmetastatic Melanoma Protein B (GPNMB) Expression in Niemann–Pick Disease Type C Model Mice

Madoka Fukaura, Yoichi Ishitsuka, Seiichi Shirakawa,

International Journal of Molecular Sciences

2021

31

In Vitro and In Vivo Evaluation of 6-O-α-Maltosyl-β-Cyclodextrin as a Potential Therapeutic Agent Against Niemann-Pick Disease Type C

Nushrat Yasmin, Yoichi Ishitsuka, Madoka Fukaura,

International Journal of Molecular Sciences

2019

22

Influence of Npc1 genotype on the toxicity of hydroxypropyl-β-cyclodextrin, a potentially therapeutic agent, in Niemann–Pick Type C disease models

Y. Tanaka, Yoichi Ishitsuka, Yusei Yamada,

Molecular Genetics and Metabolism Reports

2014

21

Differential Effects of 2-Hydroxypropyl-Cyclodextrins on Lipid Accumulation in Npc1-Null Cells

Sanzana Hoque, Yuki Kondo, Nodoka Sakata,

International Journal of Molecular Sciences

2020

21

In vivo Efficacy and Safety Evaluation of Lactosyl-β-cyclodextrin as a Therapeutic Agent for Hepatomegaly in Niemann-Pick Type C Disease

Yuki Maeda, Keiichi Motoyama, Rena Nishiyama,

Nanomaterials

2019

20

Differential mode of cholesterol inclusion with 2‐hydroxypropyl‐cyclodextrins increases safety margin in treatment of Niemann‐Pick disease type C

Yusei Yamada, Yoichi Ishitsuka, Yuki Kondo,

British Journal of Pharmacology

2021

17

Different solubilizing ability of cyclodextrin derivatives for cholesterol in Niemann–Pick disease type C treatment

Yusei Yamada, Madoka Fukaura‐Nishizawa, Asami Nishiyama,

Clinical and Translational Medicine

2023

16

Page 1